CGT | 바이오모아

CGTBiologicstaleChinese PLA General HospitalPhase 2

Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells (Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cells)

B Cell Leukemia; B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleNationwide Children's HospitalPhase 2

Universal donor derived CD33 CAR-NK (Universal donor derived CD33 CAR-NK)

Relapsed/Refractory AML · CD33

#CD33#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleVor BiopharmaPhase 2

VCAR33 (VCAR33)

Leukemia, Myeloid, Acute · Leukemia, Myeloid, Acute

#LeukemiaMyeloidAcute#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 1상태 DISCONTINUED

CGTBiologicstaleDing-Wei YePhase 2

VG161 via Intravesical Instillation (VG161 via Intravesical Instillation)

NMIBC · NMIBC

#NMIBC#CGT#Phase2#세포유전치료#CAR-T+2

CGTAAVBiologicstaleNational Institute of Allergy a…Phase 1

AAV8-VRC07 (VRC-HIVAAV070-00-GT, VRC-HIVAAV070-00-GT (AAV8-VRC07))

HIV-1 Infected Adults With Controlled Viremia · HIV-1 Infected Adults With Controlled Vi

#HIV-1InfectedAdultsWithControlle#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

WL276 CAR-T cells (WL276 CAR-T cells)

Recurrent or Progressive Glioblastoma · Recurrent or Progressive Glioblastoma

#RecurrentorProgressiveGlioblasto#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstalePaula C. & Rodger O. Riney Bloo…Phase 1

WS-CART-CS1 (WS-CART-CS1)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleUniversity of PennsylvaniaPhase 1

WT-gag-TCR modified T cells (WT-gag-TCR modified T cells)

HIV Infections · HIV Infections

#HIVInfections#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleWellington Zhaotai Therapies Li…Phase 1

1928T2z CAR-T cells (WZTL002-1, WZTL002-1 (1928T2z CAR-T cells))

Lymphomas Non-Hodgkin's B-Cell; Diffuse Large B-cell Lymphoma (DLBCL) · Lymphomas Non-Hodgkin's B-Cell

#LymphomasNon-HodgkinsB-Cell#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleXijing HospitalPhase 1

XYF19 CAR-T cell (XYF19 CAR-T cell)

Leukemia Lymphocytic Acute (ALL) in Relapse; Leukemia Lymphocytic Acute (All) Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

CGTAAVBiologicstaleYAP Therapeutics, Inc.Phase 1

AAV9-Sav-shRNA (YAP101, YAP101 (AAV9-Sav-shRNA))

Heart Failure With Reduced Ejection Fraction · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleChildren's Hospital of Fudan Un…Phase 1

alloCART-19 (alloCART-19)

ALL, Childhood B-Cell · ALL, Childhood B-Cell

#ALLChildhoodB-Cell#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleBeijing 302 HospitalPhase 2

allogeneic NK cells therapy (allogeneic NK cells therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase2#세포유전치료#CAR-T+2

CGTBiologicstaleChengdu Ucello Biotechnology Co…Phase 1

allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA (allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA)

SLE - Systemic Lupus Erythematosus · CD19

CGTBiologicstaleThe Children's Hospital of Zhej…Phase 1

anti-BCMA/CD70-CAR-T cells (anti-BCMA/CD70-CAR-T cells)

CAR T Cell Therapy; Systemic Lupus Erythematosus · BCMA

#BCMA#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleChangzhou No.2 People's HospitalPhase 1

KN5501 (anti-CD19 CAR NK cells, anti-CD19 CAR NK cells (KN5501))

Thrombocytopenia Alloimmune · CD19

CGTBiologicstaleSecond Affiliated Hospital, Sch…Phase 1

효능 ORR 0%임상시험 1상태 RECRUITING

anti-CD19 IL10/IL15 CAR-NK (anti-CD19 IL10/IL15 CAR-NK)

B-cell Non Hodgkin Lymphoma · CD19

CGTBiologicstaleThe First Affiliated Hospital o…Phase 2

anti-CD19 and anti-BCMA CAR (anti-CD19 and anti-BCMA CAR)

Safety and Efficacy · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleNational University Health Syst…Phase 1

anti-CD19 redirected NK cells (anti-CD19 redirected NK cells)

B-cell Acute Lymphoblastic Leukemia · CD19